环境新兴污染物双酚A暴露加重非酒精性脂肪性肝病大鼠脂质代谢异常*

doi:10.3969/j.issn.1672-5069.2017.06.044

Abstract

Ding Wenjin, Sun Chao, Sang Yu’er. Changes of lipid metabolism induced by bisphenol A in rats with NAFLD[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 785-787.

[1] 陈纯真，卜景芝.婴儿肝炎综合征的合并症及病原学分析. 实用肝脏病杂志，2007，10（2）:112-113.
[2] 张旭，曹美玲. 茵栀黄对早产儿巨细胞病毒性肝炎的临床疗效研究. 中国医科大学学报，2016，45（10）:895-897.
[3] 田萌萌，杨燕. 婴儿CMV感染及巨细胞病毒性肝炎的中医药诊治进展. 中国中西医结合儿科学，2015，7（1）:7-9.
[4] 阮强，何蓉. 人巨细胞病毒感染的实验室检测与诊断. 实用儿科临床杂志，2012，27（10）：729-731．
[5] Hasosah MY，Kutbi SY，Alamri AW，et a1．Perinatal cytomegalo-virus hepatitis in Saudi infants．Saudi J Gastroenterol，2012，18（3）：208-213．
[6] 李晓军，李晓岚. 促肝细胞生长素联合更昔洛韦治疗婴儿巨细胞病毒性肝炎的疗效观察. 国际儿科学杂志，2015，42（5）:575-577.
[7] Vadry W，Rosychik RJ，Lee BE，et a1．Congenital cytomegalov-irus infection in high-risk Canadian infants：report of a pilot screening study．Can J Infect Dis Med Microbiol，2010，21（1）：12-13．
[8] 张旭，曹美玲，程威，等. 中西医结合治疗巨细胞病毒性肝炎患儿血清IL-10及IL-2水平变化. 国际儿科学杂志，2016，43（1）:84-86.
[9] 孙军英，马志英. 更昔洛韦联合人免疫球蛋白对婴儿巨细胞病毒性肝炎的疗效观察. 中国伤残医学，2016，24（7）:17-19.
[10] Piret J，Boivin G．Antiviral drug resistance in herpes viruses other than cytomegalovirus．Rev Med Virol，2014，24（3）：186-218．
[11] Mmichaels MG，Greeneegs DP，Sabo DL，et a1．Treatment of children with congenital cytomegalovirus infection with ganciclovir．Pediatr Infect Dis J，2003，22（6）：504-509．
[12] 孙佃军.更昔洛韦治疗婴儿巨细胞病毒性肝炎不良反应的临床观察. 重庆医学，2011，40（13）:1307-1308.
[13] 罗嫚丽，曹文芳，刘豫军，等. 布拉氏酵母菌联合茵栀黄口服液治疗新生儿黄疸临床观察. 山东医药，2016，56（8）:79-80.
[14] 曹美玲，张沙沙，穆亚平，等. 茵栀黄口服液治疗新生儿巨细胞病毒性肝炎的疗效观察. 中国小儿急救医学，2013，20（1）:89-90.
[15] 翟美娟. 茵陈汤临床应用研究进展.中国现代药物应用，2014，23（8）:237-239.

Changes of lipid metabolism induced by bisphenol A in rats with NAFLD

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
[2]	Xu Fei, Li Weirong.. Protective effects of astragaloside in rats with CCL₄-induced liver injuries [J]. Journal of Practical Hepatology, 2019, 22(6): 808-811.
[3]	Gao Lei, Cao Lei, Wang Ruifang, et al.. Protective effect of human umbilical cord mesenchymal stem cell transplantation on alcoholic liver injury in rats [J]. Journal of Practical Hepatology, 2019, 22(6): 812-815.
[4]	Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
[5]	Lin Qiuxiang, Wang Xuewen, Huang Zuxiong, et al. Protective effects of breviscapine on liver and intestinal mucosal barrier functions in rats with hepatic ischemia-reperfusion injury [J]. Journal of Practical Hepatology, 2019, 22(5): 636-639.
[6]	Shi Xiaolong, Du Rui, Qin Geping, et al. Protective effect of sevoflurane on sepsis-induced liver injury in rats [J]. Journal of Practical Hepatology, 2019, 22(5): 640-643.
[7]	Wang Yan, Su Feng, Li Yuanyuan, et al. Protective effect of bee venom hemolysin on rats with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 474-477.
[8]	Zhang Lanhua, Shao Qin, Xia Zhenjuan. Changes of serum 25-(OH) D3 and IL-17 levels are associated with progress of nonalcoholic fatty liver disease in obese children [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 522-525.
[9]	Zhou Liyun, Li Xiaotian, Li Li. 1,25（OH）₂D₃ inhibits hepatic fibrosis by regulating miR-146a levels in vitro and in vivo [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 333-336.
[10]	Huo Huiqin, Gong Xiaohong, Li Zhenghong. Assessment of right atrial and ventricular functions in patients with nonalcoholic fatty liver disease-induced liver cirrhosis by real-time three-dimensional echocardiography and speckle tracking imaging [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 244-247.
[11]	Xie Xiao, Lu Lungen. Noninvasive diagnosis and assessment of patients with nonalcoholic steatohepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 301-306.
[12]	Guo Liping, Zhang Chenghong, Ning Baoshuo, et al.. An improved approach for seperating hepatocytes from neonatal rats in vitro [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 17-20.
[13]	Yusup Tursun, Zhao Yanxia.. Establishment of low-dose diethylnitrosamine-induced liver fibrosis model in rats [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 33-36.
[14]	Zhong Yan, Su Shuting, Mi Yuqiang.. Treatment of patients with nonalcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 145-148.
[15]	Liu Enqiang, Chen Guo, Liao Xiuyong, et al.. Inhibition of TGF-β1/Smad/ERK passway by astaxanthin in rats with CCl₄-induced liver fibrosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 842-846.